For example, cancer drugs with actionable drug-gene pairs (e.g., CYP2D6-tamoxifen, DPYD-fluoroucil, DPYD-tegafur, UGT1A1-irinotecan, DPYD-capecitabine) could be considered. This evidence concerns the gene UGT1A1 and cancer.